BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 17, 2014
View Archived Issues
Cellerant's development of CLT-008 supported by additional government funding
Read More
Mimetas awarded funding for kidney-on-a-chip nephrotoxicity model
Read More
Evotec and the Jain Foundation expand dysferlin deficiency collaboration
Read More
First preclinical and clinical data presented for TLR7 agonist GSK-2245035
Read More
GlaxoSmithKline presents results for the antibacterial DNA topoisomerase 2 inhibitor
Read More
New class of compounds protects against blast-mediated TBI
Read More
Janssen Pharmaceutica provides grant to Harvard Medical School to combat DR-tuberculosis
Read More
NantBioScience and University of Colorado to develop novel anticancer drugs
Read More
Huya Bioscience establishes global joint venture with TIPR
Read More
Full results presented for SPARK study of sapropterin in infants with phenylketonuria
Read More
Janssen describes novel agents targeting elongation factor 2 for cancer
Read More
Results for the follow-up portion of phase II study evaluating blosozumab
Read More
RADIANCE results demonstrate RPC-1063 is a promising candidate for relapsing MS
Read More
CellProThera and BioCardia agree to partner on phase II EXCELLENT trial
Read More
Lysophospholipid S1P1 receptor modulators disclosed in Allergan patent
Read More
Janssen reports discovery of TLR7/TLR8 agonists
Read More
Merck KGaA patents cathepsin D inhibitors
Read More
GSK exercises option to novel muscle disease target discovered by Five Prime
Read More
Amarantus BioScience completes enrollment in Alzheimer's disease blood test trial
Read More
NicOx obtains antiviral eye drop program from Marinomed
Read More
DCVax-L is the first drug to be designated by U.K. authorities as a PIM
Read More
Eylea receives FDA breakthrough therapy designation for diabetic retinopathy
Read More
Oxygen Biotherapeutics will change name to Tenax Therapeutics
Read More
FDA approves naloxegol for opioid-induced constipation in patients with chronic pain
Read More
Denovo Biopharma licenses enzastaurin for development as a personalized therapy for DLBCL
Read More
